BeOne Medicines Ltd. (ONC)
NASDAQ: ONC
· Real-Time Price · USD
321.57
11.88 (3.84%)
At close: Aug 15, 2025, 3:59 PM
321.00
-0.18%
After-hours: Aug 15, 2025, 07:27 PM EDT
BeOne Medicines Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.56B | 4.18B | 3.81B | 3.32B | 3.1B | 2.76B | 2.46B | 2.2B | 1.81B | 1.56B | 1.42B | 1.25B | 1.07B | 877.04M | 1.18B | 1.06B | 947.04M | 862.69M |
Cost of Revenue | 660.63M | 634.16M | 594.09M | 539.36M | 465.21M | 845.83M | 1.21B | 1.62B | 2.03B | 1.96B | 1.93B | 1.89B | 1.78B | 1.73B | 1.62B | 1.52B | 1.49B | 1.4B |
Gross Profit | 3.9B | 3.54B | 3.22B | 2.78B | 2.63B | 1.92B | 1.25B | 579.48M | -220.79M | -405.11M | -511.06M | -636.66M | -714.29M | -848.85M | -447.86M | -459.33M | -545.53M | -537.81M |
Operating Income | -100.7M | -295.75M | -568.2M | -872.57M | -886.27M | -1.1B | -1.21B | -1.29B | -1.6B | -1.72B | -1.79B | -1.89B | -1.92B | -1.95B | -1.44B | -1.35B | -1.33B | -1.21B |
Interest Income | 27.8M | 37.52M | 47.84M | 40.03M | 56.03M | 57.88M | 57.73M | 75.95M | 62.06M | 58.42M | 52.48M | 34.26M | 21.5M | 10.07M | n/a | n/a | n/a | 1.11M |
Pretax Income | -63.21M | -268.68M | -533M | -798.42M | -470.78M | -732.32M | -825.84M | -906.03M | -1.69B | -1.88B | -1.96B | -2.12B | -2B | -1.92B | -1.44B | -1.33B | -1.34B | -1.19B |
Net Income | -177.64M | -392.37M | -644.79M | -3.15B | -2.81B | -3.07B | -3.17B | -3.68B | -4.46B | -4.65B | -4.73B | -2.15B | -2.01B | -1.91B | -1.41B | -1.3B | -1.31B | -1.17B |
Selling & General & Admin | 1.96B | 1.86B | 1.83B | 1.74B | 1.65B | 1.6B | 1.5B | 1.42B | 1.38B | 1.31B | 1.28B | 1.26B | 1.2B | 1.1B | 990.12M | 891.83M | 783.44M | 675.2M |
Research & Development | 2.04B | 1.97B | 1.95B | 1.91B | 1.86B | 1.83B | 1.78B | 1.73B | 1.7B | 1.66B | 1.64B | 1.62B | 1.55B | 1.53B | 1.46B | 1.38B | 1.38B | 1.31B |
Other Expenses | 17K | 17K | 1.76M | 1.76M | 1.76M | -62.06M | -63.63M | -63.44M | -63.26M | 750K | 751K | -10.02M | 21.27M | 20.21M | 15.9M | 34.61M | 8.84M | 29.69M |
Operating Expenses | 4B | 3.84B | 3.78B | 3.65B | 3.52B | 3.01B | 2.46B | 1.87B | 1.38B | 1.31B | 1.28B | 1.26B | 1.2B | 1.1B | 990.87M | 892.58M | 784.19M | 675.95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.22M | 30.98M | 42.41M | 52.48M | 34.26M | 21.5M | 10.07M | n/a | n/a | n/a | 1.11M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.66B | 4.47B | 4.38B | 4.19B | 3.98B | 3.86B | 3.67B | 3.5B | 3.41B | 3.27B | 3.21B | 3.14B | 2.99B | 2.83B | 2.62B | 2.41B | 2.28B | 2.08B |
Income Tax Expense | 114.44M | 123.69M | 111.78M | 166.56M | 157.44M | 156.63M | 160.39M | 141.35M | 133.75M | 133.94M | 135.47M | 32.06M | 6.51M | -7.58M | -25.23M | -33.41M | -22.61M | -23.86M |
Shares Outstanding (Basic) | 8.33M | 106.93M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 104.67M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 91.46M |
Shares Outstanding (Diluted) | 8.66M | 111.17M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 106.95M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 96.73M |
EPS (Basic) | 9.23 | -3.77 | -6.24 | -30.29 | -27.04 | -29.51 | -30.42 | -35.49 | -42.9 | -44.85 | -45.76 | -21.32 | -20.41 | -20.02 | -14.95 | -14.04 | -14.43 | -13.52 |
EPS (Diluted) | 7.54 | -3.77 | -6.24 | -30.29 | -27.17 | -29.64 | -30.55 | -35.62 | -42.9 | -44.85 | -45.76 | -21.32 | -20.41 | -20.02 | -15.08 | -14.17 | -14.56 | -13.65 |
EBITDA | 89.25M | -117.3M | -397.26M | -728.05M | -791.54M | -1B | -1.12B | -1.21B | -1.52B | -1.65B | -1.72B | -1.83B | -1.86B | -1.9B | -1.39B | -1.31B | -1.29B | -1.18B |
EBIT | -100.7M | -295.75M | -568.2M | -872.57M | -886.27M | -1.1B | -1.21B | -1.29B | -1.6B | -1.72B | -1.79B | -1.89B | -1.92B | -1.95B | -1.44B | -1.35B | -1.33B | -1.21B |
Depreciation & Amortization | 189.96M | 178.45M | 170.94M | 144.51M | 94.73M | 92.96M | 87.67M | 81.87M | 76.56M | 69.69M | 66.28M | 61.38M | 57.36M | 53.42M | 46.46M | 41.16M | 37.33M | 33.67M |